Stimulation programming and recommended therapy settings

The system addresses patient challenges in adjusting neuromodulation therapy parameters by displaying recommended values, enhancing patient control and battery efficiency through subsensory threshold awareness.

WO2026236170A1PCT designated stage Publication Date: 2026-11-12MEDTRONIC INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/US2026/026636
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-07
Filing Date
2026-05-05
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Patients using neuromodulation therapy struggle to adjust therapy parameters effectively, often overshooting the necessary intensity due to lack of perceptible sensation at subsensory levels, leading to inefficiencies and battery drain.

Method used

A system that displays a recommended therapy parameter value alongside the current value, allowing patients to adjust while considering subsensory thresholds, thereby facilitating appropriate adjustments and conserving battery power.

Benefits of technology

Enhances patient control over therapy settings, improves battery longevity, and ensures effective treatment by displaying recommended values, reducing the need for higher-than-necessary adjustments.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2026026636_12112026_PF_FP_ABST
    Figure US2026026636_12112026_PF_FP_ABST
Patent Text Reader

Abstract

A system can include a memory configured to store a recommended therapy parameter value for a patient therapy and is configured to control a display device to present a user interface screen including a graphical representation of a current therapy parameter value that at least partially defines the patient therapy; determine that the recommended therapy parameter value is stored in the memory; and responsive to determining that the recommended therapy parameter value is stored in the memory, configure the user interface screen to include a graphical representation of the recommended therapy parameter value with the graphical representation of the current therapy parameter value; receive user input adjusting the current therapy parameter value; control the user interface screen to update the current therapy parameter value according to the user input; and control a medical device to deliver the patient therapy according to the updated current therapy parameter value.
Need to check novelty before this filing date? Find Prior Art

Description

Docket No.: A0012533W001 / 1123-897W001 STIMULATION PROGRAMMING AND RECOMMENDED THERAPY SETTINGS

[0001] This application claims the benefit of U.S. Provisional Application Serial No.63 / 801,589, filed May 7, 2025, which is entitled “STIMULATION PROGRAMMING AND RECOMMENDED THERAPY SETTINGS” and is hereby incorporated by reference in its entirety.TECHNICAL FIELD

[0002] This disclosure generally relates to user interfaces for programming electrical stimulation therapy.BACKGROUND

[0003] Medical devices may be external or implanted and may be used to deliver electrical stimulation therapy to various tissue sites of a patient to treat a variety of symptoms or conditions such as one or more of bladder dysfunction, e.g., retention, overactive bladder, urgency, urgency frequency, urinary incontinence, bladder incontinence, stress incontinence, or nocturia, bowel dysfunction, e.g., fecal incontinence, intractable constipation, irritable bowel syndrome, inflammatory bowel disease, chronic pain, stroke, spinal cord injury, neuropathy, tremor, Parkinson’s disease, multiple sclerosis, other movement disorders, epilepsy, sexual dysfunction, obesity, gastroparesis, pelvic pain, interstitial cystitis, sleep apnea, neural control of prosthetic devices, or stimulation to provide peripheral sensation. A medical device may deliver electrical stimulation therapy via one or more leads that include electrodes located proximate to target locations associated with the brain, the spinal cord, pelvic nerves, peripheral nerves, or the gastrointestinal tract of a patient. Hence, electrical stimulation may be used in different therapeutic applications, such as deep brain stimulation (DBS), spinal cord stimulation (SCS), pelvic stimulation, gastric stimulation, or peripheral nerve field stimulation (PNFS). An external programmer with a user interface may be used to program a medical device or retrieve information from the medical device.SUMMARY

[0004] In general, this disclosure describes devices, systems, and techniques for configuring a user interface screen for neuromodulation therapy, e.g., sacral neuromodulation (SNM) therapy. As an example, a system including a user interface, processing circuitry, and a memory, e.g., a memory of an external device or a memory of an implantable medical device (IMD), may be configured to store a recommended therapy parameter value for patient therapy. The processingDocket No.: A0012533W001 / 1123-897W001 circuitry may be configured to determine whether a recommended therapy parameter value is stored in the memory. In some examples, if there is a recommended therapy parameter value stored in the memory, the processing circuitry may configure a user interface screen of the user interface to include a graphical representation of the recommended therapy parameter value and a graphical representation of a current therapy parameter value simultaneously. The current therapy parameter value may include a therapy parameter value being used for patient therapy. A user, e.g., a patient, can adjust the current therapy parameter value by interacting with the user interface. The user interface screen can continue to display the recommended therapy parameter value while the user adjusts the current therapy parameter value.

[0005] In some examples, the recommended therapy parameter value may be an intensity level or at some magnitude in which the value is a therapeutic subsensory therapy parameter value, e.g., the patient is not able to feel the stimulation. Providing patient therapy at a subsensory therapy parameter value, e.g., a subsensory therapy current or voltage amplitude, may provide efficacious therapy while also consuming less battery power than providing patient therapy at a therapy parameter value the patient can feel. Since the patient is not able to feel patient therapy delivered at the subsensory therapy parameter value, the patient may have difficulty finding the appropriate value or may set the current therapy parameter to a higher value than necessary for effective treatment. By displaying the recommended therapy parameter value, the devices, systems, and techniques of this disclosure facilitate appropriate adjustments to the current therapy parameter value and / or re-setting the value if the patient desires to try again from the starting point provided by the clinician.

[0006] In some examples, the system may be configured to deliver patient therapy via a plurality of therapy programs. Each therapy program can be associated with a different recommended therapy parameter value. When the user switches between therapy programs, the user interface screen may display the user interface screen including the graphical representation of the recommended therapy parameter value and the graphical representation of the current therapy parameter value. When the user switches between therapy programs, processing circuitry may initially set the current therapy parameter value to a predetermined value, a most recently used value, or the recommended therapy parameter value. The user can adjust the current therapy parameter value.

[0007] In one example, a system includes: a memory configured to store a recommended therapy parameter value for a patient therapy; processing circuitry configured to: control a display device to present a user interface screen of a user interface to include a graphical representation of a current therapy parameter value that at least partially defines the patient therapy; determine that the recommended therapy parameter value is stored in the memory; andDocket No.: A0012533W001 / 1123-897W001 responsive to determining that the recommended therapy parameter value is stored in the memory, configure the user interface screen of the user interface to include a graphical representation of the recommended therapy parameter value with the graphical representation of the current therapy parameter value; receive, via the user interface, user input adjusting the current therapy parameter value; control the user interface screen to update the current therapy parameter value according to the user input; and control a medical device to deliver the patient therapy according to the updated current therapy parameter value.

[0008] In another example, a method includes: controlling, by processing circuitry of a system, a display device to present a user interface screen of a user interface to include a graphical representation of a current therapy parameter value that at least partially defines the patient therapy; determining, by the processing circuitry, that a recommended therapy parameter value for a patient therapy is stored in a memory of the system; and responsive to determining that the recommended therapy parameter value is stored in the memory, configuring, by the processing circuitry, the user interface screen of the user interface to include a graphical representation of the recommended therapy parameter value with the graphical representation of the current therapy parameter value; receiving, via the user interface, user input adjusting the current therapy parameter value; controlling, by the processing circuitry, the user interface screen to update the current therapy parameter value according to the user input; and controlling, by the processing circuitry, a medical device to deliver the patient therapy according to the updated current therapy parameter value.

[0009] In another example, a non-transitory computer-readable medium stores instructions that when executed cause processing circuitry to: control a display device to present a user interface screen of a user interface to include a graphical representation of a current therapy parameter value that at least partially defines the patient therapy; determine that a recommended therapy parameter value for a patient therapy is stored in a memory of the system; and responsive to determining that the recommended therapy parameter value is stored in the memory, configure the user interface screen of the user interface to include a graphical representation of the recommended therapy parameter value with the graphical representation of the current therapy parameter value; receive, via the user interface, user input adjusting the current therapy parameter value; control the user interface screen to update the current therapy parameter value according to the user input; and control a medical device to deliver the patient therapy according to the updated current therapy parameter value.

[0010] The details of one or more examples of the techniques of this disclosure are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the techniques will be apparent from the description and drawings, and from the claims.Docket No.: A0012533W001 / 1123-897W001BRIEF DESCRIPTION OF DRAWINGS

[0011] FIG. l is a conceptual diagram illustrating an example system that manages delivery of neurostimulation to a patient to manage bladder dysfunction, such as overactive bladder, urgency, or urinary incontinence according to an example of the techniques of the disclosure.

[0012] FIG. 2 is a block diagram illustrating an example configuration of the implantable medical device (IMD) of FIG. 1 according to an example of the techniques of the disclosure.

[0013] FIG. 3 is a block diagram illustrating an example configuration of the external device of FIG. 1 according to an example of the techniques of the disclosure.

[0014] FIG. 4A, FIG. 4B, and FIG. 4C are conceptual diagrams illustrating example home screens for navigating within a user interface according to an example of the techniques of the disclosure.

[0015] FIG. 5 is a conceptual diagram illustrating an example screen for selecting a therapy program of a plurality of therapy programs within a user interface according to an example of the techniques of the disclosure.

[0016] FIG. 6 is a conceptual diagram illustrating an example screen for adjusting a therapy parameter for a selected therapy program within a user interface according to an example of the techniques of the disclosure.

[0017] FIG. 7 is a flowchart illustrating an example operation for configuring a user interface screen for adjusting a therapy parameter within a user interface based on whether a recommended value is stored according to an example of the techniques of the disclosure.

[0018] FIG. 8 is a flowchart illustrating an example operation for configuring a user interface screen for adjusting a therapy parameter within a user interface based on whether a recommended value is stored and based on a current therapy parameter value according to an example of the techniques of the disclosure.DETAILED DESCRIPTION

[0019] This disclosure describes example devices, systems, and techniques for configuring user interface screens for adjusting a therapy parameter for neuromodulation therapy to include a recommended therapy parameter value. A user, such as a patient, may be able to adjust the value of one or more parameters (e.g., amplitude, frequency, pulse width, electrode combination, etc.) that defines stimulation in order to customize the therapy to the patient over time. The patient may wish to adjust the value at the beginning of therapy as the patient gets used to therapy. In some examples, physiological or anatomical changes may occur after implantation that may also affect how the stimulation feels or how effective the therapy is. For any reason, the user mayDocket No.: A0012533W001 / 1123-897W001 adjust a stimulation value. However, the patient may adjust the value too much, or vary the parameter many times, to the point where the patient may not be able to find the value that provided effective stimulation. The clinician may provide an initial value, but once the patient deviates from that value, the patient may become “lost” when trying to adjust the value over time and prevent the delivery of effective therapy. In some examples, the initial value selected by the clinician may define stimulation that cannot be perceived by the patient (and still provides therapy), but the patient may not be able to find this value again after adjustments because the resulting stimulation around this intensity level is no perceptible by the patient.

[0020] As described herein, a system including an implantable medical device (IMD) may be configured to receive a recommended therapy parameter value. The recommended therapy parameter value may be based on user input, a sensed physiological signal, or a combination thereof. The system determines whether a memory of the system is storing the recommended therapy parameter value. If a user has set a recommended therapy parameter value and / or the processing circuitry has determined a recommended therapy parameter value and stored the recommended therapy parameter value in the memory, the system configures a user interface screen to include a graphical representation of the recommended therapy parameter value. If the system determines the memory is not storing the recommended therapy parameter value, the system configures the user interface screen to exclude the graphical representation of the recommended therapy parameter value. The user interface may display the user interface screen in response to the user adjusting the therapy parameter value. For example, the user interface screen may display the recommended therapy parameter value and an adjustable therapy parameter value at which the IMD is delivering therapy.

[0021] Some systems for configuring neuromodulation therapy may include static user interface screens that do not shift based on the presence or absence of a stored recommended therapy parameter value. By configuring the user interface screen based on the presence or absence of the stored recommended therapy parameter value, the techniques of this disclosure recite a specific example manner of automatically configuring user interface screens based on user input, which provides an improvement over prior systems with static user interfaces, resulting in an improved user interface for configuring neuromodulation therapy.

[0022] In some techniques, systems may not be configured to sense physiological signals of the patient to determine a recommended therapy parameter value. In some examples, the clinician may select therapy parameter values based on patient sensation and not based on sensed physiological signals. In such examples, therapy parameters may be less efficacious and / or may be higher than necessary compared to systems in which recommended therapy parameters areDocket No.: A0012533W001 / 1123-897W001 based on sensed physiological signals. This can lead to inefficiencies in therapy that may reduce battery longevity of the system and may also not be as effective for the patient.

[0023] These various features of the systems and techniques described herein may provide advantages over other systems and improve system functionality and patient outcomes. For example, by generating user interface screens for configuring neuromodulation therapy based on whether a recommended therapy parameter value is stored in a memory of the system, the techniques of this disclosure may allow a patient to consider the recommended therapy parameter value while adjusting the current therapy parameter value, which may help the patient select an appropriate therapy parameter value. In some examples, the recommended therapy parameter value may be below a patient sensory threshold. For example, the patient may not be able to feel the therapy at the recommended therapy parameter value. In some examples, by displaying a subsensory recommended therapy parameter value, the techniques of this disclosure may facilitate user selection of a relatively lower therapy parameter value, thereby conserving battery power of a device, resulting in increased device longevity. Increased device longevity may improve a patient experience, e.g., may improve the patient experience by facilitating more stable patient symptom control, and may additionally save a clinician’s time.

[0024] FIG. 1 is a conceptual diagram illustrating an example system 10 that manages delivery of neurostimulation to a patient 14 to manage bladder dysfunction, such as overactive bladder, urgency, or urinary incontinence according to an example of the techniques of the disclosure. As shown in the example of FIG. 1, therapy system 10 includes IMD 16 (e.g., an example medical device), which is coupled to sensor 210 (FIG. 2) (e.g., an internal sensor 210 and / or external wearable sensor 15) and one or more of lead 28. System 10 additionally includes an external device 24, which is configured to communicate with IMD 16 via wireless communication. System 10 may include server 26, which may be one or more servers in a cloud computing environment. Server 26 may be configured to communicate with external device 24 and / or IMD 16 via wireless communication through a network access point (not shown in FIG. 1) and may be collocated with external device 24 or may be located elsewhere, such as in a cloud computing data center. IMD 16 generally operates as a therapy device that delivers neurostimulation (e.g., electrical stimulation in the example of FIG. 1) to, for example, a target tissue site proximate a spinal nerve, a sacral nerve, a pudendal nerve, dorsal genital nerve, a tibial nerve, a saphenous nerve, an inferior rectal nerve, a perineal nerve, or other pelvic nerves, branches of any of the aforementioned nerves, roots of any of the aforementioned nerves, ganglia of any of the aforementioned nerves, or plexus of any of the aforementioned nerves. IMD 16 provides electrical stimulation to patient 14 by generating and delivering a programmable electrical stimulation signal (e.g., in the form of electrical pulses or an electrical waveform) to aDocket No.: A0012533W001 / 1123-897W001 target a therapy site near lead 28 and, more particularly, near electrodes 29 (electrodes 29A-29D of FIG. 2, collectively referred to as “electrodes 29”) disposed proximate to a distal end of lead 28. Electrodes 29 may be positioned near target tissue, such as a target nerve such as a sacral nerve. Lead 28 may be inserted through any portion of tissue, such as foramen 27 within sacrum 26 as shown in the example of FIG. 1.

[0025] Although described with respect to IMD 16 and bladder dysfunction management, the techniques of this disclosure are not so limited. The techniques of this disclosure may be implemented using a plurality of different types of medical devices and systems, such as any IMD configured to deliver electrical stimulation therapy. The medical devices and systems may be configured to delivery electrical stimulation therapy for managing any of bladder dysfunction, chronic pain, tremor, Parkinson’s disease, other movement disorders, epilepsy, sexual dysfunction, obesity, or gastroparesis.

[0026] IMD 16 may be surgically implanted in patient 14 at any suitable location within patient 14, such as near the pelvis. In some examples, IMD 16 may be implanted in a subcutaneous location in the side of the lower abdomen or the side of the lower back or upper buttocks. IMD 16 has a biocompatible housing, which may be formed from titanium, stainless steel, a liquid crystal polymer, or the like. The proximal ends of lead 28 is both electrically and mechanically coupled to IMD 16 either directly or indirectly, e.g., via a respective lead extension. Electrical conductors disposed within the lead bodies of lead 28 electrically connect electrodes 29 to sensing circuitry and stimulation delivery circuitry (e.g., a stimulation generator) within IMD 16. In some examples, system 10 may include electrodes, e.g., electrodes 29, and, optionally, electrodes other than electrodes 29, a strain gauge, one or more accelerometers, ultrasound sensors, optical sensors, or any other sensor. In some examples, the sensors may be configured to gather information relating to the patient, such as detect contractions of bladder 12, pressure or volume of bladder 12, or any other indication of the fill cycle of bladder 12 and / or possible bladder dysfunctional states. System 10 may use the sensor data for determining stimulation program settings for a given patient, as discussed below. IMD 16 may communicate sensed data to server 26. In some examples, IMD 16 may communicate the sensor data through external device 24. In other examples, IMD 16 may communicate the sensor data to server 26 without communicating the sensor data through external device 24.

[0027] In some examples, system 10 may not use any sensors at all. For example, external device 24 may collect user input identifying a voiding event, perceived level of fullness, or any other indication of an event associated with the patient. The user input may be in the form of a voiding journal analyzed by external device 24, IMD 16 or server 26, or individual user inputsDocket No.: A0012533W001 / 1123-897W001 associated with respective voiding events, leakage, or any other event related to the patient. External device 24 may provide this user input to server 26.

[0028] One or more medical leads, e.g., lead 28, may be connected to IMD 16 and surgically or percutaneously tunneled to place one or more electrodes carried by a distal end of the respective lead at a desired nerve or muscle site, e.g., one of the previously listed target therapy sites such as a tissue site proximate a spinal (e.g., sacral) or pudendal nerve. For example, lead 28 may be positioned such that electrodes 29 deliver electrical stimulation to a spinal, sacral or pudendal nerve to reduce a frequency and / or magnitude of contractions of bladder 12. Additional electrodes of lead 28 and / or electrodes of another lead may provide additional stimulation therapy to other nerves or tissues as well.

[0029] In the example shown in FIG. 1, lead 28 is cylindrical. Electrodes 29 may be ring electrodes, segmented electrodes, partial ring electrodes or any suitable electrode configuration. Segmented and partial ring electrodes each extend along an arc less than 360 degrees (e.g., 90-120 degrees) around the outer perimeter of lead 28. In some examples, segmented electrodes 29 of lead 28 may be useful for targeting different fibers of the same or different nerves to generate different physiological effects (e.g., therapeutic effects). In examples, one or more of lead 28 may be, at least in part, paddle-shaped (e.g., a “paddle” lead), and may include an array of electrodes on a common surface, which may or may not be substantially flat.

[0030] In some examples, one or more of electrodes 29 may be cuff electrodes that are configured to extend at least partially around a nerve (e.g., extend axially around an outer surface of a nerve). Delivering electrical stimulation via one or more cuff electrodes and / or segmented electrodes may help achieve a more uniform electrical field or activation field distribution relative to the nerve, which may help minimize discomfort to patient 14 that results from the delivery of electrical stimulation. An electrical field may define the volume of tissue that is affected when the electrodes 29 are activated. An activation field represents the neurons that will be activated by the electrical field in the neural tissue proximate to the activated electrodes.

[0031] The illustrated numbers and configurations of lead 28 and electrodes carried by lead 28 are merely exemplary. Other configurations, e.g., numbers and positions of leads and electrodes are also contemplated. For example, in other implementations, IMD 16 may be coupled to additional leads or lead segments having one or more electrodes positioned at different locations proximate the spinal cord or in the pelvic region of patient 14. The additional leads may be used for delivering different stimulation therapies or other electrical stimulations to respective stimulation sites within patient 14 or for monitoring at least one physiological marker of patient 14.Docket No.: A0012533W001 / 1123-897W001

[0032] In accordance with some examples of the disclosure, IMD 16 delivers electrical stimulation to at least one of a spinal nerve (e.g., a sacral nerve), a pudendal nerve, dorsal genital nerve, a tibial nerve, a saphenous nerve, an inferior rectal nerve, or a perineal nerve to provide a therapeutic effect that reduces or eliminates a dysfunctional state such as overactive bladder. The desired therapeutic effect may be an inhibitory physiological response related to voiding of patient 14, such as a reduction in bladder contraction frequency by a desired level or degree (e.g., percentage).

[0033] System 10 may also include an external device 24, as shown in FIG. 1. External device 24 may be an example of a computing device. In some examples, external device 24 may be a clinician programmer or patient programmer. In some examples, external device 24 may be a device for inputting patient specific configuration instructions for configuring IMD 16. In some examples, external device 24 may be a wearable communication device, with a therapy request input integrated into a key fob or a wristwatch, handheld computing device, smart phone, computer workstation, or networked computing device. External device 24 may include a user interface that is configured to receive input from a user (e.g., patient 14, a patient caretaker or a clinician). In some examples, the user interface includes, for example, a keypad and a display, which may for example, be a liquid crystal display (LCD) or light emitting diode (LED) display. In some examples, the user interface may include a tumable knob or a representation of a turnable knob. The keypad may take the form of an alphanumeric keypad or a reduced set of keys associated with particular functions. External device 24 may additionally or alternatively include a peripheral pointing device, such as a mouse, via which a user may interact with the user interface. In some examples, a display of external device 24 may include a touch screen display, and a user may interact with external device 24 via the display. It should be noted that the user may also interact with external device 24, server 26 and / or IMD 16 remotely via a networked computing device.

[0034] A user, such as a physician, technician, surgeon, electrophysiologist, or other clinician, may also interact with external device 24 or another separate programmer (not shown), such as a clinician programmer, to communicate with IMD 16 and / or server 26. Such a user may interact with external device 24 to retrieve physiological or diagnostic information from IMD 16. The user may also interact with external device 24 to program IMD 16, e.g., select values for the therapy parameter values with which IMD 16 generates and delivers stimulation and / or the other operational parameters of IMD 16, such as magnitudes of stimulation energy, user requested periods for stimulation or periods to prevent stimulation, or any other such user customization of therapy. In some examples, the user can select values, e.g., the recommended therapy parameter value and / or parameter value limits, for the therapy parameter values pre-operatively during anDocket No.: A0012533W001 / 1123-897W001 established communication session. In some examples, the user can additionally or alternatively select the values post-operatively. In some examples, the therapy parameter values may be proposed by system 10, for example, by server 26, and a user may be able to accept or reject the therapy parameter values. In other examples, the therapy parameter values may be set by system 10, for example, by server 26. As discussed herein, the user may also provide input to external device 24 indicative of physiological events such as bladder fill level perception and void events.

[0035] In some examples, the user can only select or adjust the recommended therapy parameter value and / or parameter value limits when the user is the clinician and external device 24 is a clinician programmer. Put another way, the clinician programmer may enable the user to select the recommended therapy parameter value, and the patient programmer may disable, or not provide, a feature that allows for user selection of the recommended therapy parameter value. Patient 14 may thus be able to make adjustments to one or more current therapy parameter values, but patient 14 may not be able to select or adjust the recommended therapy parameter value and / or parameter value limits.

[0036] In some examples, the user, such as a clinician or patient, may input information relating to patient 14 into external device 24 and external device 24 may collect information relating to the patient and provide that information to server 26. The information relating to a patient may include: 1) demographic information, such as gender, age, etc.; 2) medical history, such as BMI, diagnosis, comorbidities, medications, etc.; 3) baseline symptom data during a predetermined time period, such as somewhere in the range of three days to two weeks, for example. Baseline symptom data may include symptoms of a disease that the patient is experiencing. For example, baseline symptom data may include a number of or times and / or when a patient experiences an incontinence issue or a feeling of urgency to urinate. Baseline symptom data may also include volume of a urinary event or other measures indicative of the symptoms the patient may be experiencing, for example, information relating to bowel movements, pain, etc. In some examples, the patient may be prompted by external device 24 to answer questions related to their medications, lifestyle and quality of life. These questions may include questions relating to length and quality of sleep, fluid intake, food intake, food choices, activities of daily life, level of activities (e.g., step counts), exercise, pain, discomfort, etc. In some examples, these questions may be asked periodically over a period of days, such as three to four days. In some examples, the user may provide the first information relating to a patient prior to beginning treatment, during a baseline period. In other examples, the information related to the medications, lifestyle, and quality of life of the patient may be gathered in another manner, such as entered by a clinician onto external device 24. In some examples, the user may provide further information relating to a patient during other periods. For example, external device 24 mayDocket No.: A0012533W001 / 1123-897W001 prompt patient 14 to answer questions about their symptoms or the efficacy of treatment during the other periods. For example, external device 24 may prompt patient 14 to input whether patient 14 had a bladder leak that day or a number of times patient 14 had bladder leaks that day. External device 24 may collect the information relating to a patent and provide the information relating to the patient, including the answers to the questions, to server 26.

[0037] In some examples, a healthcare provider may utilize sensors, such as wearable sensor 15 or existing implanted sensors, to collect more objective patient data related to sleep, activity or disease symptoms. For example, wearable sensor 15 may be a heartrate sensor, an accelerometer and / or other sensor to collect patient data, for example, on disease symptoms or lifestyle. The patient data captured by the sensors, such as wearable sensor 15, may be provided to server 26. In some examples, the sensors, such as wearable sensor 15, may be configured to communicate with an external device, such as external device 24, via a wireless link. In some examples, external device 24 may collect the patient data generated by the sensors and send the patient data to server 26. In other examples, another device may collect the patient data generated by the sensors and send the patient data to server 26.

[0038] For example, the user may use external device 24 to retrieve information from IMD 16 relating to the contraction frequency of bladder 12 and / or voiding events. As another example, the user may use external device 24 to retrieve information from IMD 16 relating to the performance or integrity of IMD 16 or other components of system 10, such as lead 28, or a power source of IMD 16. In some examples, this information may be presented to the user as an alert if a system condition that may affect the efficacy of therapy is detected.

[0039] The user of external device 24 may also communicate with server 26. For example, the user of external device 24 may provide information relating to the patient to server 26, such as demographic information, medical history, lifestyle information, bladder events, level of satisfaction with therapy, or sensor data.

[0040] Patient 14 may, for example, use a keypad or touch screen of external device 24 to request IMD 16 to deliver or terminate the electrical stimulation, such as when patient 14 senses that a leaking episode may be imminent or when an upcoming void may benefit from terminating therapy that promotes urine retention. In this way, patient 14 may use external device 24 to provide a therapy request to control the delivery of the electrical stimulation “on demand,” e.g., when patient 14 deems the stimulation therapy desirable. This request may be a therapy trigger event used to terminate electrical stimulation. Patient 14 may also use external device 24 to provide other information to IMD 16, such as information indicative of a phase of a physiological cycle, such as the occurrence of a voiding event.Docket No.: A0012533W001 / 1123-897W001

[0041] IMD 16 and external device 24 may communicate via wireless communication using any techniques known in the art. Examples of communication techniques may include, for example, low frequency or radiofrequency (RF) telemetry, but other techniques are also contemplated. In some examples, external device 24 may include a programming lead that may be placed proximate to the body of the patient near the IMD 16 implant site in order to improve the quality or security of communication between IMD 16 and external device 24.

[0042] IMD 16 also may include a sensor 210 (FIG. 2) for detecting changes in the contraction of bladder 12 and / or evoked activity in response to stimulation. Sensor 210 may include, for example, electrodes for sensing sacral evoked responses (SER), electrodes for sensing electromyogram (EMG) signals, e.g., pelvic floor muscles such as the levator ani or urinary sphincter EMG signals (or anal sphincter EMG signals in examples in which system 10 provides therapy to manage fecal urgency or fecal incontinence), electrodes for sensing evoked compound action potentials (ECAPS), a pressure sensor for detecting changes in bladder pressure, or any combination thereof. In examples in which sensor 210 is a pressure sensor, the pressure sensor may be a remote sensor that wirelessly transmits signals to IMD 16 or may be carried on lead 28 or an additional lead coupled to IMD 16. In some examples, IMD 16 may determine whether a contraction frequency of bladder 12 has occurred based on a pressure signal generated by sensor 210. In some examples, IMD 16 may control the timing of the delivery of the electrical stimulation based on input received from sensor 210.

[0043] Sensor 210 may comprise a patient motion sensor that generates a signal indicative of patient activity level or posture state. In some examples, IMD 16 may terminate the delivery of the electrical stimulation to patient 14 upon detecting a patient activity level exceeding a particular threshold based on the signal from the motion sensor. In other examples, IMD 16 may use sensor 210 to identify posture states known to require the desired therapeutic effect. For example, patient 14 may be more prone to an involuntary voiding event when patient 14 is in an upright posture state compared to when patient 14 is in a supine posture state. In any event, sensor 210 may be configured to detect voiding events and / or the magnitude of a fill level of bladder 12 during the fill cycle.

[0044] System 10 may include memory configured to store first information relating to a patient, wherein the first information is captured during a baseline period that is prior to the patient receiving stimulation, and processor circuitry coupled to the memory, the processor circuitry being configured to receive the first information relating to the patient, receive second information relating to the patient, wherein the second information is captured during an initial therapy assignment and the second information comprises testing data generated by delivering stimulation during an implant procedure, determine initial stimulation program settings based onDocket No.: A0012533W001 / 1123-897W001 the first information, the second information and population-informed information, the population-informed information being related to other patients, and cause, during a training period, delivery of therapy based on the initial stimulation program settings.

[0045] FIG. 2 is a block diagram illustrating an example configuration of IMD 16 of FIG. 1 according to an example of the techniques of the disclosure. As shown in FIG. 2, IMD 16 includes sensor 210, processing circuitry 202, therapy delivery circuitry 212, sensing circuitry 211, memory 216, communication circuitry 214, and power source 222. In other examples, IMD 16 may include a greater or fewer number of components. IMD 16 may be configured to deliver electrical stimulation, e.g., neuromodulation therapy, in an open loop or closed loop manner.

[0046] According to some examples, processing circuitry 202 identifies changes to the physiological state of the patient that are relevant to desired changes in neurostimulation. For example, voiding of the bladder may indicate that stimulation is not required for a certain time or until sensor input indicates otherwise. The system may include one or more sensors that sense biomarkers indicative of a change in the relevant physiological state(s), e.g., sensor 210 and / or sensors external to IMD 16. For example, a pressure sensor may detect the amount of bladder pressure. Thus, processing circuitry 202 may be configured to classify certain changes in bladder pressure as corresponding to a void (e.g., when the sensed signals match one or more sets of parameters). Processing circuitry 202 may also classify the relative fullness of the bladder from subsequently detected pressure levels.

[0047] Specified parameters of the bladder pressure signal may be used to inform processing circuitry 202 to identify when voiding events have occurred. For instance, and without limitation, processing circuitry 202 may monitor one or more of bladder pressure, the amount of change in bladder pressure, the duration of change in bladder pressure, and the rate of change in bladder pressure. This data may serve to identify a voiding event. It should be noted that other nerve targets may alter urinary function in a manner that is similar to sacral nerves, such as the tibial nerve, saphenous nerve, pudendal nerve, dorsal nerve of the penis, and the dorsal nerve of the clitoris.

[0048] Sensing circuitry 211 may be configured to sense, via one or more of electrodes 29, a signal generated by one or more nerves or one or more muscles in response to the electrical stimulation, such as one or more of an evoked compound action potential (ECAP), a electromyography (EMG) signal, or a sacral evoked response (SER). ECAPS are stimulation-evoked signals that can be sensed via electrodes on the sacral lead. Using ECAPS and EMG signals, e.g., using features of ECAPs and EMG signals, such as signal threshold magnitude and signal magnitude, a clinician can determine therapy parameters. SERs, which are stimulation-evoked signals that can be sensed via electrodes on the sacral lead, may be considered as aDocket No.: A0012533W001 / 1123-897W001 composite of one or more EMG signals and / or one or more ECAPs or other neural signal. EMG signals may include EMG signals of levator ani or pelvic floor muscles. EMG signals may include EMG signals of the external anal sphincter muscle, coccygeus muscle, levator ani muscle group, bulbocavernosus and / or bulbospongiosus muscle, gluteal muscles, e.g., gluteal maximus, gluteal medius, and gluteal minimus, perineal muscles, ischiocavemosus muscles, puborectalis muscles, piriformis muscles, or any other muscles.

[0049] In some examples, features of ECAPs, EMGs, and / or SERs may include one or more of a signal peak, a signal peak amplitude, a number of signal peaks, an area under signal peaks, a signal peak width, a time between signal peaks, a ratio of signal peak amplitudes, a ratio of signal peak widths, a ratio of areas under signal peaks, a latency of a signal peak, a signal valley, a signal valley amplitudes, a number of signal valleys, an area above a signal valley, a signal valley width, a time between signal valleys, a ratio of signal valley amplitudes, a ratio of signal valley widths, a ratio of areas above signal valleys, a valley latency, a root-mean-square signal value, a signal skew, a signal kurtosis, a signal frequency, a signal spectral content, a Hjorth feature, a signal amplitude growth curve threshold, a signal amplitude growth curve inflection point amplitude, a signal amplitude growth curve inflection point latency, a signal amplitude growth curve saturation point, a signal strength duration curve chronaxie, a signal strength duration curve rheobase or another signal strength duration curve feature, a signal maximum rate of change feature, e.g., a maximum of a derivative of the signal, or a signal minimum rate of change feature, e.g., a minimum of a derivative of the signal, or any other suitable feature.

[0050] The same or different electrodes may be used to generate stimulation and detect the response signal. In some examples, different sets of electrodes may be used to deliver stimulation and sense a physiological response to the delivered stimulation. Sensing circuitry 211 may receive respective sensed signals from one or more electrodes, such as one or more of electrodes 29, evoked from the electrical stimulation delivered according to the electrical therapy parameter set. One or more switches, multiplexers, or other hardware may be configured to connect, or disconnect, sensing circuitry 211 and therapy delivery circuitry 212 from any of electrodes 29.

[0051] In some examples, sensing circuitry 211 may perform signal processing of each received signal to remove noise or other unwanted frequencies or artifacts (e.g. stimulation, motion, cardiac, etc.). Sensing circuitry 211 may also convert the analog signal to a digital signal and / or provide other signal processing functionality. Processing circuitry 202 may operate in conjunction with sensing circuitry 211 to evaluate or analyze the received physiological signal, e.g., the SER, the EMG, and / or the ECAP, for one or more characteristics, such as one or more signal peaks, peak amplitudes, number of peaks, areas under peaks, peak widths, time between peaks, ratios of peak amplitudes, widths, and / or areas, peak latency, signal valleys, valleyDocket No.: A0012533W001 / 1123-897W001 amplitudes, number of valleys, areas above valleys, valley widths, time between valleys, ratios of valley amplitudes, widths, and / or areas, valley latency, root-mean-square signal value, signal skew, kurtosis, frequency and / or spectral content of the signal(s), or any other suitable signal feature. Using one or more of these characteristics of the sensed signal, processing circuitry 202 may determine whether or not the respective parameter set defined effective stimulation or if a different therapy parameter set may be more effective. Once processing circuity 202 determines that a therapy parameter set defined stimulation that evoked a desired response from the patient, processing circuity 202 may update the parameters that define the pairs of pulses that are defined by the parameter set. In some examples, processing circuity 202 may adjust and / or recommend adjusting one or more parameters to use the new parameter value identified as being more effective instead of a previous parameter value.

[0052] In general, IMD 16 may comprise any suitable arrangement of hardware, alone or in combination with software and / or firmware, to perform the techniques attributed to IMD 16 and processing circuitry 202, therapy delivery circuitry 212, sensing circuitry 211, and communication circuitry 214 of IMD 16. In various examples, IMD 16 may include one or more processors, such as one or more microprocessors, digital signal processors (DSPs), application specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), or any other equivalent integrated or discrete logic circuitry, as well as any combinations of such components. IMD 16 also, in various examples, may include a memory 216, such as random access memory (RAM), read only memory (ROM), programmable read only memory (PROM), erasable programmable read only memory (EPROM), electronically erasable programmable read only memory (EEPROM), flash memory, comprising executable instructions for causing the one or more processors to perform the actions attributed to them. Moreover, although processing circuitry 202, therapy delivery circuitry 212, and communication circuitry 214 are described as separate circuitry, in some examples, processing circuitry 202, therapy delivery circuitry 212, sensing circuitry 211, and communication circuitry 214 are functionally integrated. In some examples, processing circuitry 202, therapy delivery circuitry 212, sensing circuitry 211, and communication circuitry 214 correspond to individual hardware units, such as microprocessors, ASICs, DSPs, FPGAs, or other hardware units. In further examples, any of processing circuitry 202, therapy delivery circuitry 212, sensing circuitry 211, and communication circuitry 214 may correspond to multiple individual hardware units such as microprocessors, ASICs, DSPs, FPGAs, or other hardware units.

[0053] Memory 216 may store any information or instructions that processing circuitry 202 uses to configure the user interface, as described herein, such as the recommended therapy parameter value. Memory 216 stores therapy programs 218 that specify therapy parameter valuesDocket No.: A0012533W001 / 1123-897W001 for the electrical stimulation provided by IMD 16. In some examples, during a communication session, e.g., a BLE communication session, established between external device 24 and IMD 16 during a period of time before implantation of IMD 16 within patient 14, external device 24 may generate one or more user interface screens for configuring sensing circuitry 210 and stimulation circuitry, e.g., therapy delivery circuitry 212. External device 24 may generate a first user interface screen requesting user input selecting an express setup option or a guided setup option. Based on the user selection, processing circuitry 202 may generate a second user interface screen. Processing circuitry 202 may configure the plurality of user interface screens using a machine learning model. Processing circuitry 202 may configure therapy programs 218 based on user input collected via the plurality of user interface screens. As examples, processing circuitry 202 may determine a recommended therapy amplitude, e.g., a voltage or current amplitude, a recommended ramping rate, and / or a recommended pulse width for one or more therapy programs 218. Therapy programs 218 may also store information related to determining and using physiological markers, information relating to physiological cycles and / or dysfunctional states, or any other information during open loop and closed loop electrical stimulation delivery.

[0054] Memory 216 can store recommended value(s) 220. Recommended value(s) 220 may include one or more recommended therapy parameter values, e.g., a recommended therapy voltage amplitude, a recommended therapy current amplitude, a recommended electrode combination for therapy delivery, and / or a recommended therapy pulse width. Recommended value(s) 220 may include patient specific values. In some examples, a user, e.g., a clinician, may set the recommended therapy parameter value(s). In some examples, processing circuitry 202 determines, based on one or more sensed physiological signals, e.g., an SER, an EMG, and / or an ECAP sensed via electrodes 29, the recommended therapy parameter value(s). In some examples, the clinician confirms or adjusts the recommended therapy parameter value(s) determined by processing circuitry 202. In some examples, only the clinician can confirm or adjust recommended therapy parameter value(s). Patient 14 may be able to make adjustments to one or more therapy parameters but may not be able to select or adjust the recommended therapy parameter value and / or parameter value limits.

[0055] Recommended therapy parameter values may be subsensory therapy parameter values. Patient 14 may be unable to feel the therapy. In some examples, processing circuitry 202 and / or the user may determine the recommended therapy parameter value(s) are subsensory and may store that information. In some examples, processing circuitry 202 configures the user interface screen of the user interface to include an indication that the recommended therapy parameter value(s) are subsensory. In some examples, the user interface screen may only display the recommended therapy parameter value(s) when the current therapy parameter value fallsDocket No.: A0012533W001 / 1123-897W001 below one or more thresholds. In some examples, the threshold may comprise the recommended therapy value(s). In some examples, memory 216 may store different recommended value(s) 220 for each therapy program of therapy programs 218. For example, memory 216 may store a first therapy program, a second therapy program, and a third therapy program of therapy programs 218. Memory 216 may store recommended value(s) 220 including a first recommended therapy parameter value(s) corresponding to the first therapy program, a second recommended therapy parameter value(s) corresponding to the second therapy program, and / or a third recommended therapy parameter value(s) corresponding to the third therapy program. In some examples, one or more therapy programs 218 may not have a corresponding recommended therapy parameter value(s). For example, if the user does not configure one or more therapy programs during a setup session, memory 216 may not store recommended therapy value(s) for those one or more therapy programs.

[0056] Information related to sensed bladder contractions and / or posture of patient 14 may be recorded for long-term storage and retrieval by a user, to be used by processing circuitry 202 for adjustment of therapy parameters (e.g., amplitude, pulse width, pulse rate, duty cycle, etc.) or for use as a physiological signal, or to be sent to server 26. In some examples, memory 216 includes separate memories for storing instructions, electrical signal information, therapy programs 218, and recommended value(s) 220.

[0057] Generally, therapy delivery circuitry 212 generates and delivers electrical stimulation under the control of processing circuitry 202. In some examples, processing circuitry 202 controls therapy delivery circuitry 212 by accessing memory 216 to selectively access and load at least one of therapy programs 218 to therapy delivery circuitry 212. For example, in operation, processing circuitry 202 may access memory 216 to load one of therapy programs 218 to therapy delivery circuitry 212. In other examples, therapy delivery circuitry 212 may access memory 216 and load one of the therapy programs 218.

[0058] By way of example, processing circuitry 202 may access memory 216 to load one of therapy programs 218 to therapy delivery circuitry 212 for delivering the electrical stimulation to patient 14. A clinician or patient 14 may select a particular one of therapy programs 218 from a list using a programming device, such as external device 24, which may be a patient or clinician programmer. Processing circuitry 202 may receive the selection via communication circuitry 214. Therapy delivery circuitry 212 delivers the electrical stimulation to patient 14 according to the selected program for an extended period of time, such as minutes, hours, days, weeks, or until patient 14 or a clinician manually stops or changes the program.

[0059] Therapy delivery circuitry 212 delivers electrical stimulation according to therapy parameters. In some examples, therapy delivery circuitry 212 delivers electrical stimulation in theDocket No.: A0012533W001 / 1123-897W001 form of electrical pulses. In such examples, relevant therapy parameters may include a voltage amplitude, a current amplitude, a pulse rate, a pulse width, a duty cycle, a duty cycle of the stimulation ON / OFF periods, or the combination of electrodes, e.g., electrodes 29, that therapy delivery circuitry 212 uses to deliver the stimulation signal. In other examples, therapy delivery circuitry 212 delivers electrical stimulation in the form of continuous waveforms. In such examples, relevant therapy parameters may include a voltage or current amplitude, a frequency, a shape of the stimulation signal, a duty cycle of the stimulation signal, or the combination of electrodes 29 therapy delivery circuitry 212 uses to deliver the stimulation signal.

[0060] In some examples, the therapy parameters for the stimulation programs 218 may be selected to relax bladder 12, e.g., to reduce a frequency of contractions of bladder 12, after termination of the electrical stimulation. An example range of therapy parameters for the electrical stimulation that are likely to be effective in treating bladder dysfunction, e.g., upon application to the spinal, sacral, pudendal, tibial, saphenous, dorsal genital, inferior rectal, or perineal nerves, are as follows:1. Frequency or pulse rate: between about 0.5 Hz and about 500 Hz, such as between about 1 Hz and about 250 Hz, between about 1 Hz and about 20 Hz, or about 10 Hz.2. Amplitude: between about 0.1 volts and about 50 volts, such as between about 0.5 volts and about 20 volts, or between about 1 volt and about 10 volts. Alternatively, the amplitude may be between about 0.1 milliamps (mA) and about 50 mA, such as between about 0.5 mA and about 20 mA, or between about 1 mA and about 10 mA.3. Pulse Width: between about 10 microseconds (ps) and about 5000 ps, such as between about 100 ps and about 1000 ps, or between about 100 ps and about 200 ps.

[0061] In some examples, processing circuitry 202 may monitor signals received from sensor 210 and / or electrodes 29 to detect contraction of bladder 12 and determine the baseline contraction frequency. In some examples, sensor 210 may be a pressure sensor for detecting changes in pressure of bladder 12, which processing circuitry 202 may correlate to contractions of bladder 12. Processing circuitry 202 may determine a pressure value based on signals received from sensor 210 and compare the determined pressure value to a threshold value to determine whether the signal is indicative of a contraction of bladder 12. In some implementations, processing circuitry 202 monitors pressure of bladder 12 to detect contractions of bladder 12 for a predetermined duration of time and determines a contraction frequency of bladder 12 by calculating a number of contractions of bladder 12 in the predetermined time period.

[0062] In the example of FIG. 2, therapy delivery circuitry 212 drives electrodes on a single lead 28. Specifically, therapy delivery circuitry 212 delivers electrical stimulation to tissue of patient 14 via selected electrodes 29A-29D carried by lead 28. A proximal end of lead 28 extendsDocket No.: A0012533W001 / 1123-897W001 from the housing of IMD 16 and a distal end of lead 28 extends to a target therapy site, such as a spinal nerve (e.g., an S3 nerve), or a therapy site within the pelvic floor, such as tissue sites proximate a sacral nerve, a pudendal nerve, a tibial nerve, a saphenous nerve, a dorsal genital nerve, an inferior rectal nerve, a perineal nerve, a hypogastric nerve, a urinary sphincter, or any combination thereof. In other examples, therapy delivery circuitry 212 may deliver electrical stimulation with electrodes on more than one lead, e.g., one or more of leads 18, 20, and 28, and each of the leads may carry one or more electrodes. The leads may be configured as an axial lead with ring electrodes or segmented electrodes and / or paddle leads with electrode pads arranged in a two-dimensional array. The electrodes may operate in a bipolar or multi-polar configuration with other electrodes or may operate in a unipolar configuration referenced to an electrode carried by the device housing or “can” of IMD 16.

[0063] As previously described, sensor 210 may comprise a pressure sensor configured to detect changes in bladder pressure, electrodes for sensing pudendal or sacral nerve signals (afferent or efferent), or electrodes for sensing pelvic EMG signals (ex. levator ani, urinary sphincter, or anal sphincter signals in examples in which IMD 16 provides fecal urgency or fecal incontinence therapy), or any combination thereof. Additionally, or alternatively, sensor 210 may comprise a motion sensor, such as a two-axis accelerometer, three-axis accelerometer, one or more gyroscopes, pressure transducers, piezoelectric crystals, or other sensors that generate a signal that changes as patient activity level or posture state changes. Processing circuitry 202 may detect a physiological marker indicative of point during a bladder fill cycle. Sensor 210 may also be a motion sensor that is responsive to tapping (e.g., by patient 14) on skin superior to IMD 16. Processing circuitry 202 may be configured to log patient input using this tapping method (e.g., tapping may indicate that a voiding event is occurring). Alternatively, or in addition, processing circuitry 202 may control therapy delivery circuitry 212 to deliver or terminate electrical stimulation delivery in response to the tapping or certain pattern of tapping.

[0064] In examples in which sensor 210 includes a motion sensor, processing circuitry 202 may determine a patient activity level or posture state based on a signal generated by sensor 210. This patient activity level may be, for example, sleeping, sitting, exercising, working, running, walking, or any other activity of patient 14. For example, processing circuitry 202 may determine a patient activity level by sampling the signal from sensor 210 and determining a number of activity counts during a sample period, where each activity level of a plurality of activity levels is associated with respective activity counts. In one example, processing circuitry 202 compares the signal generated by sensor 210 to one or more amplitude thresholds stored within memory 216 and identifies each threshold crossing as an activity count. The physical activity may beDocket No.: A0012533W001 / 1123-897W001 indicative of a fill level, a voiding event, or any other physiological marker related to the bladder fill cycle.

[0065] Power source 222 delivers operating power to the components of IMD 16. Power source 222 may include a battery and a power generation circuit to produce the operating power. Generally, processing circuitry 202 may control communication circuitry 214 to exchange information with external device 24 or another device external to IMD 16, such as server 26. Processing circuitry 202 may transmit operational information, therapy programs 218, and / or sensing parameters 220 and receive stimulation programs or therapy parameter adjustments via communication circuitry 214. Also, in some examples, IMD 16 may communicate with other implanted devices, such as stimulators, control devices, or sensors, via communication circuitry 214. In examples in which memory 216 stores recommended value(s) 220, communication circuitry 214 may communicate the recommended value(s) 220 to an external device, e.g., external device 24. External device 24 may display recommended value(s) via a user interface of external device 24 corresponding to a therapy program in use by patient 14.

[0066] FIG. 3 is a block diagram illustrating an example configuration of external device 24 of FIG. 1 according to an example of the techniques of the disclosure. While external device 24 may generally be described as a hand-held computing device, external device 24 may be a notebook computer, a smart phone, or a workstation, for example. As illustrated in FIG. 3, external device 24 may include a processing circuitry 302, memory 304, user interface 310, communication circuitry 306, and power source 308. Memory 304 may store program instructions that, when executed by processing circuitry 302, cause processing circuitry 302 and external device 24 to provide the functionality ascribed to external device 24 throughout this disclosure.

[0067] In general, external device 24 comprises any suitable arrangement of hardware, alone or in combination with software and / or firmware, to perform the techniques attributed to external device 24, and processing circuitry 302, user interface 310, and communication circuitry 306 of external device 24. In various examples, external device 24 may include one or more processors, such as one or more microprocessors, DSPs, ASICs, FPGAs, or any other equivalent integrated or discrete logic circuitry, as well as any combinations of such components. External device 24 also, in various examples, may include a memory 304, such as RAM, ROM, PROM, EPROM, EEPROM, flash memory, a hard disk, a CD-ROM, comprising executable instructions for causing the one or more processors to perform the actions attributed to them. Moreover, although processing circuitry 302 and communication circuitry 306 are described as separate circuitry, in some examples, processing circuitry 302, and communication circuitry 306 are functionally integrated. In some examples, processing circuitry 302 and communication circuitry 306 andDocket No.: A0012533W001 / 1123-897W001 communication circuitry 214 correspond to individual hardware units, such as microprocessors, ASICs, DSPs, FPGAs, or other hardware units. In other examples, any of processing circuitry 302, communication circuitry 306, communication circuitry 214 may correspond to multiple individual hardware units, such as microprocessors, ASICs, DSPs, FPGAs, or other hardware units. Communication circuitry 306 may be configured to communicate with IMD 16 via a local wireless communication technique that may be employed to facilitate communication between external device 24 and IMD 16, such as RF communication according to the 802.11 or Bluetooth specification sets, e.g., Bluetooth Low Energy (BLE) specification sets, infrared communication, e.g., according to the IrDA standard, or other standard or proprietary telemetry protocols.

[0068] Memory 304 may store program instructions that, when executed by processing circuitry 302, cause processing circuitry 302 and external device 24 to provide the functionality ascribed to external device 24 throughout this disclosure. In some examples, memory 304 may further include program information, e.g., therapy programs defining the neurostimulation, similar to those stored in memory 216 of IMD 16. The therapy programs stored in memory 304 may be downloaded into memory 216 of IMD 16.

[0069] Memory 304 may be configured to store recommended value(s) 312, which may include one or more recommended therapy parameter values. In some examples, the one or more recommended therapy parameter values may correspond to one or more corresponding therapy programs. In some examples, external device 24 may receive, via communication circuitry 306, one or more recommended therapy parameter values from IMD 16. For example, during a communication session with IMD 16, IMD 16 may send recommended value(s) 218 to external device 24. In some examples, IMD 16 may send recommended value(s) 218 to external device 24 in response to user interaction with external device 24. In some examples, communication circuitry 306 may be configured to transmit recommended value(s) 312 to IMD 16. For example, when the user, e.g., a clinician, configures IMD 16 for delivering patient therapy, external device 24 may send recommended value(s) to IMD 16 for storage in memory 216. External device 24, e.g., a patient programmer, may subsequently receive the stored recommended value(s) from IMD 16 during communication sessions with IMD 16. The clinician may confirm, adjust, or select recommended value(s) 312 during an initial configuration session using external device 24, e.g., a clinician programmer. In some examples, the clinician may update and / or confirm updates to recommended value(s) 312 during a follow-up visit after the initial configuration session. In some examples, the clinician may update recommended value(s) 312 remotely.

[0070] External device 24 includes a user interface 310 that allows the user, e.g., patient 14 and / or the clinician, to provide input, e.g., instructions for configuring IMD 16 and / or instructions for adjusting patient therapy. The clinician or patient 14 may provide informationDocket No.: A0012533W001 / 1123-897W001 relating to patient 14 to external device 24 through user interface 310. For example, during a preimplantation period and / or during a baseline period after implantation, the clinician, guided by a plurality of user interface screens of user interface 310, may input instructions for configuring IMD 16, such as instructions for configuring one or more therapy programs and / or therapy parameter values. The clinician may also provide input indicative of demographic information, medical history, and / or baseline symptom data of patient 14.

[0071] User interface 310 may include a button or keypad, lights, a speaker for voice commands, a turnable knob, a display, such as a liquid crystal (LCD), light-emitting diode (LED), or cathode ray tube (CRT). In some examples the display may be a touch screen. As discussed in this disclosure, processing circuitry 302 may present and receive information relating to electrical stimulation and resulting therapeutic effects via a plurality of user interface screens of user interface 310. For example, processing circuitry 302 may receive patient input via user interface 310. The input may be, for example, in the form of pressing a button on a keypad or selecting an icon from a touch screen.

[0072] Processing circuitry 302 may also present information to the patient in the form of alerts or notifications related to delivery of the patient therapy, e.g., electrical stimulation, to patient 14 or a caregiver via user interface 310. Although not shown, external device 24 may additionally or alternatively include a data or network interface to another computing device, to facilitate communication with the other device, and presentation of information relating to the electrical stimulation and therapeutic effects after termination of the electrical stimulation via the other device.

[0073] Examples of local wireless communication techniques that may be employed to facilitate communication between external device 24 and another computing device include RF communication according to the 802.11 or Bluetooth specification sets, e.g., BLE specification sets, infrared communication, e.g., according to the IrDA standard, or other standard or proprietary telemetry protocols. In this manner, other external devices may be capable of communicating with external device 24 without needing to establish a secure wireless connection.

[0074] In some examples, e.g., in examples in which external device 24 comprises a smartphone, user interface 310 may be configured to output notifications to the user. As an example, user interface 310 may output a notification to the user to run sensing to determine one or more recommended therapy parameter values. As another example, in response to user input indicative of one or more patient symptoms or side effects, user interface 310 may be configured to output a notification to the user suggesting that the user adjusts the current therapy parameter value to the recommended therapy parameter value.Docket No.: A0012533W001 / 1123-897W001

[0075] Power source 308 delivers operating power to the components of external device 24. Power source 308 may include a battery and a power generation circuit to produce the operating power. In some examples, the battery may be rechargeable to allow extended operation.

[0076] FIGS. 4A, 4B, and 4C are conceptual diagrams illustrating example home screens for navigating within a user interface 400, according to an example of the techniques of the disclosure. In the example of FIG. 4A, home screen 416 is configured for navigating within user interface 400. In this manner, user interface 400 may include home screen 416. User interface 400 may be an example of user interface 310 of external device 24. For example, user interface 400 may be an example of user interface 310 of external device 24 when external device 24 is configured for use by a clinician and / or when external device 24 is configured to configure patient therapy, such as during a setup period. User interface 400 may include several different screens that the user, e.g., the clinician, can navigate to, each of the screens having different functions to view sensed information, view stored data, and / or adjust various therapy programs and therapy parameter values. As shown in the example of FIG. 4 A, home screen 416 includes therapy settings 408, patient information 410, and device status 412. Home screen 416 additionally includes disconnect button 414 to end a wireless connection between external device 24 and IMD 16.

[0077] Device status 412 may include an estimated battery life of IMD 16 and an impedance status. In some examples, the user may click on device status 412 to view a pop-up screen with additional device status information. The additional device status information can include information captured in the operating room during implantation of IMD 16, such as a fluoroscopy information, CT scan information, MRI information, etc. Patient information 410 may include a name of patient 14, a date of birth of patient 14, implant location, and date of implantation. In some examples, the user can edit information of patient 14 by clicking patient information 410. Patient information 410 can additionally include a diagnosis of patient 14 and time since patient 14 was diagnosed, predominant symptoms of patient 14, and / or prioritized outcome goals for patient 14.

[0078] Therapy settings 408 includes a pop-up window 402 for prompting a therapy configuration. Therapy settings 408 can also include trialing data, such as a preferred therapy program and stimulation amplitude. The user can select run sensing button 404 to sense the physiological signal and determine recommended therapy parameters and / or therapy parameter limits, e.g., stimulation voltage amplitude, pulse width, electrode combination for therapy delivery, and / or ramp rate, for neuromodulation therapy delivery based on the physiological signal. In some examples, the therapy parameter values may be subsensory for patient 14. The user can alternatively select manual configuration button 406 and set therapy parametersDocket No.: A0012533W001 / 1123-897W001 manually. For example, the user may set the therapy voltage amplitude based on patient sensation of stimulation. The recommended therapy parameter values and / or therapy parameter limits can be patient specific. In some examples, processing circuitry 302 and / or the clinician may determine updated therapy parameter values and / or therapy parameter value limits over time. As an example, the clinician may initially set recommended therapy parameter values during implantation of IMD 16. The clinician may update the recommended therapy parameter values during a subsequent clinic visit. The clinician may additionally or alternatively update the recommended therapy parameter values remotely. In some examples, processing circuitry 302 may update the recommended therapy parameter values based on a sensed physiological signal, e.g., an EMG, an SER, and / or an ECAP signal, according to a periodic schedule, e.g., every 3 months. In some examples, user interface 400 may prompt a user, e.g., a clinician or patient 14, to run sensing on the periodic schedule. In some examples, processing circuitry 302 may update the recommended therapy parameter values based on a reported efficacy, a biomarker signal, or a change in patient state. In some examples, processing circuitry 302 may control user interface 400 to output an indication to the clinician to update the recommended therapy value. In some examples, processing circuitry 302 may update the recommended therapy parameter values according to a pre-programmed change over time and / or with a mode change. As an example, processing circuitry 302 may be configured to increase or decrease the recommended therapy parameter values incrementally over time to correspond to changes in patient state over time. In some examples, processing circuitry 302 may update the recommended therapy parameter values in response to a mode of IMD 16 being changed. In some examples, the modes of IMD 16 may comprise an “ON” mode and an “OFF” mode. The “OFF” mode may operate as a safety state with stimulation parameters defining a relatively low stimulation intensity or low power usage and the “ON” mode may operate as a treatment state with stimulation parameters defining a relatively high stimulation intensity or higher power usage.

[0079] FIG. 4B is an example conceptual diagram of a home screen 418 for navigating user interface 400. FIG. 4B includes a list of programs 420, an amplitude indicator 424, a graphical representation of an electrode combination 426, therapy indicator 428, and a run sensing button 422. In the example of FIG. 4B, therapy indicator 428 is set to “ON.” List of programs 420 may include a plurality of programs. The programs of list of programs 420 may be organized based on user, e.g., patient or clinician preference, a stimulation amplitude value, historical use, and / or user input. Amplitude indicator 424 includes an indication of a current therapy amplitude for a selected program of list of programs 420. The user can adjust the current therapy amplitude value. Home screen 418 may include graphical representation of the electrode combination 426. Graphical representation of the electrode combination 426 includes an indication of whichDocket No.: A0012533W001 / 1123-897W001 electrodes of a lead are associated with the selected program of list of programs 420. In the example of FIG. 4B, the selected program of list of programs 420 is program 1.

[0080] The user can select run sensing button 422 such that, in response to receiving selection of run sensing button 422, system 10 responsively senses the physiological signal and determines recommended therapy parameters and / or therapy parameter limits, e.g., stimulation voltage amplitude, pulse width, electrode combination, and / or ramp rate, for neuromodulation therapy delivery based on the physiological signal. In some examples, the therapy parameter values may be subsensory for patient 14. In some examples, run sensing button 422 may be similar to run sensing button 404 of FIG. 4A. In the example of FIG. 4B, if the user does not select run sensing button 422, the user may determine recommended therapy parameters and / or therapy parameter limits manually.

[0081] FIG. 4C is another example conceptual diagram of a home screen 420 for navigating user interface 400. FIG. 4C includes list of programs 420, therapy indicator 428, and run sensing button 422. FIG. 4C may be substantially similar to FIG. 4B. In the example of FIG. 4C, therapy indicator 428 is set to “OFF.” When therapy indicator 428 is set to “OFF,” the user may not be able to adjust an amplitude of amplitude indicator 424. In this manner, in the OFF configuration, the system may disable any user adjustment to amplitude. Similar to FIG. 4B, the user can select run sensing button 422 such that, in response to receiving selection of run sensing button 422, system 10 can determine one or more stimulation parameters based on a sensed physiological signal. Otherwise, the user can select stimulation amplitude settings manually.

[0082] FIG. 5 is a conceptual diagram illustrating an example screen 502 for selecting a therapy program of a plurality of therapy programs within a user interface 500 according to an example of the techniques of the disclosure. User interface 500 may be an example of user interface 310 of external device 24. For example, user interface 500 may be an example of user interface 310 of external device 24 when external device 24 is configured for use by a patient, e.g., patient 14, such as when patient 14 determines to switch between therapy programs and / or adjust a therapy parameter value. User interface 500 may include several different screens that the user, e.g., patient 14, can navigate to, each of the screens having different functions to view sensed information, view stored data, and / or adjust various therapy programs and therapy parameter values. User interface 500 may be intended to be used on a patient programmer, but a clinician programmer or other type of programmer may provide a similar screen.

[0083] User interface 500 may include a home screen (not depicted). Patient 14 may navigate to screen 502 from the home screen. Screen 502 includes exit button 504. Patient 14 can return to the home screen using exit button 504. Screen 502 includes program options 506. A user, e.g., patient 14, may select a program of program options 506 for use in patient therapy delivery. InDocket No.: A0012533W001 / 1123-897W001 some examples, program options 506 may display therapy programs stored in one or more of memory 216 or memory 304. Patient 14 may be able to scroll to view additional therapy programs of program options 506. The order in which program options 506 displays therapy programs may be based on current patient use, historical patient use, patient preference, and / or clinician preference. As an example, if patient 14 is currently using program 8 of program options 506, user interface screen 502 may display program 8 at the top of the list of program options 506. In some examples, the order in which program options 506 displays therapy programs may additionally or alternatively be based on whether the therapy programs are associated with any stored recommended therapy parameter values. For example, if the clinician did not set a recommended therapy parameter value for a therapy program, the therapy program may be displayed lower in the list of program options 506. In some examples, the order in which program options 506 displays therapy programs may additionally or alternatively be based on a user recommendation, such as a user recommended stimulation amplitude. As an example, the user may recommend programs of program options 506 associated with lower amplitudes. User interface screen 502 may display programs with lower amplitudes higher in the list of program options 506.

[0084] The selected program option of program options 506 may be highlighted, bolded, or otherwise designated as the selected program option. Screen 502 includes a current program button 508 indicative of the therapy program currently in use. In the example of FIG. 5, the current program is program 8. In some examples, user interface 500 may generate a pop-up screen in response to patient 14 selecting a program of program options 506 requesting confirmation of the selection.

[0085] FIG. 6 is a conceptual diagram illustrating an example screen 602 of for adjusting a therapy parameter for a selected therapy program within user interface 500 according to an example of the techniques of the disclosure. In examples in which user interface 500 comprises a user interface of a smartphone, user interface 500 may include a button 618. Patient 14 can exit a patient therapy application by clicking button 618. Patient 14 may navigate to screen 602 from screen 502 or from the home screen. Screen 602 includes exit button 504. Patient 14 can return to screen 502 or the home screen by selecting exit button 504. Screen 602 includes a program dropdown box 604. When patient 14 selects program dropdown box 604, user interface 500 may display screen 502 or may display a pop-up window including a list of selectable therapy program options. In the example of FIG. 6, the current therapy program is therapy program 8, as designated in program dropdown box 604. Therapy status 608 includes an indication of whether therapy is “ON” or “OFF.” When therapy is ON, IMD 16 may be delivering, via therapy delivery circuitry 212, patient therapy, e.g., electrical stimulation, to patient 14. In some examples, patientDocket No.: A0012533W001 / 1123-897W001 14 can select therapy status 608 to switch therapy ON and OFF. Current therapy parameter value representation 610 includes a representation of the current therapy parameter value being used for patient therapy delivery. In some examples, processing circuitry 302 and / or processing circuitry 202 may initially set the current therapy parameter to a default value. The default value can be patient specific. In some examples, the default value is the recommended therapy parameter value. In some examples, the default value is the value most recently used with the selected therapy program. In some examples, each therapy program is associated with a corresponding default value. The default value may be the same or different for each therapy program.

[0086] In the example of screen 602, the current therapy parameter is a current amplitude value of 1.3 milliamps. The current therapy parameter value representation 610 can additionally or alternatively include a voltage amplitude value, a pulse width value, an electrode combination, and / or a pulse frequency value. In some examples, patient 14, may only be able to adjust one current therapy parameter, e.g., the current amplitude value. To adjust the current therapy parameter value, patient 14 can select increase button 612 to increase the current therapy parameter value and can select decrease button 614 to decrease the current therapy parameter value. In some examples, patient 14 can select an increment at which increase button 612 and decrease button 614 adjust the current therapy parameter value. In some examples, the increment is predetermined. In some examples, patient 14 may be able to adjust the current therapy parameter value within limits determined during set up, e.g., limits determined by processing circuitry 302 and / or processing circuitry 202 and / or limits designated by the clinician during set up. For example, the clinician may set a maximum current therapy parameter value that patient 14 cannot exceed. Increase button 612 may become grayed out if the current therapy parameter value reaches the limit set by the clinician. In some examples, the patient 14 can adjust the current therapy parameter value by typing in an updated current therapy parameter value.

[0087] Recommended therapy parameter value representation 616 is a recommended therapy parameter value. In the example of screen 602, the recommended therapy parameter value is a recommended current amplitude value of 0.2 milliamps. Processing circuitry of system 10, e.g., processing circuitry 302, may configure screen 602 to display recommended therapy parameter value representation 616 in response to a determination that a recommended therapy parameter value is stored in memory 216 and / or memory 304. In some examples, external device 24 may receive an indication of the recommended therapy parameter value from IMD 16. Processing circuitry 302 may only configure screen 602 to display recommended therapy parameter value representation 616 when a recommended therapy parameter value is stored in memory 216 and / or 304. For example, processing circuitry 302 may configure screen 602 to excludeDocket No.: A0012533W001 / 1123-897W001 recommended therapy parameter value representation 616. Without recommended therapy parameter value representation 616, processing circuitry 302 may merely not add the recommended therapy parameter value representation 616 from screen 602 and may present other items of screen 602 in different ways (e.g., larger or differently positioned current therapy parameter value representation 610 and / or buttons 612 or 614). In some examples, processing circuitry 302 may configure screen 602 to provide an indication or warning that no recommended value is available if there is no recommended therapy parameter value stored in memory. In some examples, by configuring screen 602 based on the presence or absence of the stored recommended therapy parameter value, the techniques of this disclosure recite a specific example manner of automatically configuring a user interface screen based on user input, which provides an improvement over prior systems with static user interfaces, resulting in an improved user interface for configuring neuromodulation therapy. For example, a static user interface screen might depict recommended therapy parameter value representation 616 as a blank box when there is not a recommended therapy parameter value stored in memory 216 and / or 304, whereas the techniques of this disclosure include excluding recommended therapy parameter value representation 616 when there is not a recommended therapy parameter value stored in memory 216 and / or 304.

[0088] In some examples, recommended therapy parameter value representation 616 may include an indication of whether the recommended therapy parameter value is subsensory for patient 14. Recommended therapy parameter value representation 616 may additionally or alternatively include an indication of whether the recommended therapy parameter value was set by a clinician, determined by processing circuitry 302 based on a physiological signal, e.g., an SER, and EMG, an ECAP, or a combination thereof.

[0089] In some examples, processing circuitry 302 may be configured to configure screen 602 to include recommended therapy parameter value representation 616 when the current therapy parameter value meets a criterion. For example, processing circuitry 302 may configure screen 602 to include recommended therapy parameter value representation 616 when the current therapy parameter value is less than a threshold value. In some examples, the threshold value is based on the recommended therapy parameter value. In some examples, the threshold value is based on a patient sensation threshold value. For example, processing circuitry 302 may set the threshold value to the therapy parameter value at which patient 14 begins to be able to feel the patient therapy.

[0090] FIG. 7 is a flowchart illustrating an example operation for configuring a user interface screen for adjusting a therapy parameter within a user interface based on whether a recommended value is stored in memory according to an example of the techniques of the disclosure.Docket No.: A0012533W001 / 1123-897W001 Processing circuitry of system 10, e.g., processing circuitry 302, controls a display device, e.g., external device 24, to present a user interface screen of a user interface to include a graphical representation of a current therapy parameter value (702). In some examples, the graphical representation of the current therapy parameter value may be similar to or the same as current therapy parameter value representation 610 of screen 602. Processing circuitry 302 determines whether a recommended therapy parameter value is stored in memory of system 10, e.g., memory 216 and / or memory 304 (704). In some examples, IMD 16 stores recommended therapy parameter value(s) in memory 216. During communication sessions with external device 24, IMD 16 may transmit the recommended therapy parameter value(s) to external device 24.

[0091] If the recommended therapy parameter value is stored in memory 216 and / or memory 304 (“YES” branch of block 704), processing circuitry 302 configures the user interface screen to include a graphical representation of the recommended therapy parameter value (706). In some examples, the graphical representation of the recommended therapy parameter value is similar to or the same as recommended therapy parameter value representation 616 of screen 602. In some examples, the graphical representation of the recommended therapy parameter value may include an indication of whether the recommended therapy parameter value is subsensory. If the recommended therapy parameter value is not stored in memory 216 and / or memory 304 (“NO” branch of block 704), processing circuitry 302 configured the user interface screen to exclude the graphical representation of the recommended therapy parameter value (708). Exclusion of the recommended therapy parameter value may include a different arrangement of other items presented in the user interface, such as sizing and / or placement of other items of the screen.

[0092] In some examples, processing circuitry 302 receives user input, via the user interface, adjusting the current therapy parameter value (710). As an example, processing circuitry may receive an indication that patient 14 selected increase button 612 or decrease button 614.Processing circuitry 302 updates the current therapy parameter value (712). While processing circuitry 302 updates the current therapy parameter value, the user interface screen continues to display the graphical representation of the recommended therapy parameter value. Processing circuitry 302 controls a medical device, e.g., IMD 16, to delivery patient therapy according to the updated current therapy parameter value (714).

[0093] In examples in which the patient therapy is delivered in a closed loop manner, processing circuitry 302 may control IMD 16 to deliver patient therapy based on a physiological signal associated with patient therapy at the therapy parameter value of the patient. As an example, if patient 14 updates the current therapy current amplitude value to 1.6 milliamps, processing circuitry 302 may determine one or more features of the physiological signal whenDocket No.: A0012533W001 / 1123-897W001 patient 14 set the current therapy parameter value to 1.6 milliamps and may adjust the therapy current amplitude value to maintain the one or more features of the physiological signal.

[0094] In some examples, the recommended therapy parameter value is a first recommended therapy value corresponding to a first therapy program of a plurality of therapy programs associated with IMD 16. In some examples, processing circuitry 302 may, for each therapy program of the plurality of therapy programs, perform the example operation of FIG. 7. For example, for a second therapy program of the plurality of therapy programs, processing circuitry 302 may determine whether memory 216 and / or 304 is storing a second recommended therapy value corresponding to the second therapy program of the plurality of therapy programs. If the second recommended therapy value is stored, processing circuitry 302 configures the user interface screen to include a graphical representation of the second recommended therapy parameter value.

[0095] Although the example operation of FIG. 7 is described with respect to processing circuitry 302 of external device 24, the techniques of this disclosure are not so limited. The example operation of FIG. 7 can additionally or alternatively be performed by processing circuitry 202 of IMD 16 or another device of system 10, e.g., another device in communication with server 26.

[0096] FIG. 8 is a flowchart illustrating an example operation for configuring a user interface screen for adjusting a therapy parameter within a user interface based on whether a recommended value is stored in memory and based on a current therapy parameter value according to an example of the techniques of the disclosure.

[0097] Processing circuitry of system 10, e.g., processing circuitry 302, controls a display device, e.g., external device 24, to present a user interface screen of a user interface to include a graphical representation of a current therapy parameter value (802). In some examples, the graphical representation of the current therapy parameter value may be similar to or the same as current therapy parameter value representation 610 of screen 602. Processing circuitry 302 determines whether a recommended therapy parameter value is stored in memory of system 10, e.g., memory 216 and / or memory 304 (804). In some examples, IMD 16 stores recommended therapy parameter value(s) in memory 216. During communication sessions with external device 24, IMD 16 may transmit the recommended therapy parameter value(s) to external device 24.

[0098] If the recommended therapy parameter value is not stored in memory 216 and / or memory 304 (“NO” branch of block 804), processing circuitry 302 configures the user interface screen to exclude the graphical representation of the recommended therapy parameter value (810). If the recommended therapy parameter value is stored in memory 216 and / or memory 304 (“YES” branch of block 804), processing circuitry 302 determines whether a current therapyDocket No.: A0012533W001 / 1123-897W001 parameter value meets a criterion. For example, processing circuitry 302 determines whether the current therapy parameter value meets a threshold value (806). In some examples, the threshold value is based on a patient sensation threshold. For example, the clinician and / or processing circuitry 302 may determine a therapy parameter value at which patient 14 is able to feel the patient therapy. The clinician and / or processing circuitry 302 may set the threshold value to the patient sensation threshold. In some examples, the threshold value is additionally or alternatively based on the recommended therapy parameter value.

[0099] In some examples, processing circuitry 302 determines the current therapy parameter value meets the threshold value when the current therapy value is less than the threshold value. In such examples, if the current therapy parameter value is less than the threshold value (“YES” branch of block 806), processing circuitry 302 configures the user interface screen to include a graphical representation of the recommended therapy parameter value (808). In some examples, the graphical representation of the recommended therapy parameter value may be similar to or the same as recommended therapy parameter value representation 616 of screen 602. If the current therapy parameter value is not less than the threshold value (“NO” branch of block 806), processing circuitry 302 configures the user interface screen to exclude the graphical representation of the recommended therapy parameter value (810).

[0100] In some examples, by displaying the graphical representation of the recommended therapy parameter value when the current therapy parameter value is less than the threshold value, e.g., the patient sensation threshold, the techniques of this disclosure may assist patient 14 in selecting an efficacious subsensory therapy parameter value. It may be relatively more important to display the graphical representation of the recommended therapy parameter value when patient 14 is not able to feel the patient therapy than when the patient is able to feel the patient therapy.

[0101] In some examples, processing circuitry 302 determines the current therapy parameter value meets the threshold value when the current therapy value is greater than the threshold value. In such examples, if the current therapy parameter value is greater than the threshold value (“YES” branch of block 806), processing circuitry 302 configures the user interface screen to include a graphical representation of the recommended therapy parameter value (808). In some examples, the graphical representation of the recommended therapy parameter value may be similar to or the same as recommended therapy parameter value representation 616 of screen 602. If the current therapy parameter value is not greater than the threshold value (“NO” branch of block 806), processing circuitry 302 configures the user interface screen to exclude the graphical representation of the recommended therapy parameter value (810).Docket No.: A0012533W001 / 1123-897W001

[0102] In some examples, by displaying the graphical representation of the recommended therapy value when the current therapy parameter value is greater than the threshold value, the techniques of this disclosure may encourage patient 14 to select a current therapy parameter value that is efficacious even when patient 14 is not able to feel the current therapy parameter value, e.g., when the current therapy parameter value is subsensory.

[0103] Example 1. A system comprising: a memory configured to store a recommended therapy parameter value for a patient therapy; processing circuitry configured to: control a display device to present a user interface screen of a user interface to include a graphical representation of a current therapy parameter value that at least partially defines the patient therapy; determine that the recommended therapy parameter value is stored in the memory; and responsive to determining that the recommended therapy parameter value is stored in the memory, configure the user interface screen of the user interface to include a graphical representation of the recommended therapy parameter value with the graphical representation of the current therapy parameter value; receive, via the user interface, user input adjusting the current therapy parameter value; control the user interface screen to update the current therapy parameter value according to the user input; and control a medical device to deliver the patient therapy according to the updated current therapy parameter value.

[0104] Example 2. The system of example 1, wherein the processing circuitry is configured to determine that the recommended therapy parameter value is stored in the memory by at least: determining that the current therapy parameter value is less than a threshold value; and responsive to determining that the current therapy parameter value is less than the threshold value, configuring the user interface screen to include the recommended therapy parameter value and the graphical representation of the current therapy parameter value.

[0105] Example 3. The system of example 2, wherein the processing circuitry is configured to determine the threshold value based on a patient sensation threshold corresponding to the therapy parameter value.

[0106] Example 4. The system of any of examples 1 through 3, wherein the processing circuity is configured to configure the user interface screen of the user interface to include the graphical representation of the recommended therapy parameter value by at least: configuring the user interface screen to include the graphical representation of the recommended therapy parameter value in response to user interaction with the user interface screen.

[0107] Example 5. The system of any of examples 1 through 4, wherein the processing circuitry is configured to determine the recommended therapy parameter value during an initial configuration session with a clinician programmer.Docket No.: A0012533W001 / 1123-897W001

[0108] Example 6. The system of any of examples 1 through 5, wherein the recommended therapy parameter value comprises a sub sensory therapy parameter value that is below a sensory threshold of the patient.

[0109] Example 7. The system of any of examples 1 through 6, wherein the user interface is configured to: receive user input selecting the recommended therapy parameter value; and responsive to the user input selecting the recommended therapy parameter value, set the current therapy parameter value to the recommended therapy parameter.

[0110] Example 8. The system of any of examples 1 through 7, further comprising the display device.

[0111] Example 9. The system of any of examples 1 through 8, wherein the recommended therapy parameter value comprises one or more of: a current amplitude; a pulse width; or a pulse frequency.

[0112] Example 10. The system of any of examples 1 through 9, wherein the processing circuitry is further configured to adjust the recommended parameter value based on one or more of a sensed physiological signal or clinician input.

[0113] Example 11. The system of any of examples 1 through 10, further comprising an implantable medical device (IMD) that includes the memory, wherein the IMD is configured to deliver the patient therapy.

[0114] Example 12. The system of any of examples 1 through 11, wherein the system further comprises an implantable medical device (IMD) configured to deliver the patient therapy, and wherein the patient therapy comprises neuromodulation therapy.

[0115] Example 13. The system of example 12, wherein the neuromodulation therapy comprises sacral neuromodulation (SNM) therapy.

[0116] Example 14. The system of example 12, wherein the neuromodulation therapy comprises pudendal neuromodulation therapy.

[0117] Example 15. A method comprising: controlling, by processing circuitry of a system, a display device to present a user interface screen of a user interface to include a graphical representation of a current therapy parameter value that at least partially defines the patient therapy; determining, by the processing circuitry, that a recommended therapy parameter value for a patient therapy is stored in a memory of the system; and responsive to determining that the recommended therapy parameter value is stored in the memory, configuring, by the processing circuitry, the user interface screen of the user interface to include a graphical representation of the recommended therapy parameter value with the graphical representation of the current therapy parameter value; receiving, via the user interface, user input adjusting the current therapy parameter value; controlling, by the processing circuitry, the user interface screenDocket No.: A0012533W001 / 1123-897W001 to update the current therapy parameter value according to the user input; and controlling, by the processing circuitry, a medical device to deliver the patient therapy according to the updated current therapy parameter value.

[0118] Example 16. The method of example 15, wherein determining that the recommended therapy parameter value is stored in the memory comprises: determining that the current therapy parameter value is less than a threshold value; and responsive to determining that the current therapy parameter value is less than the threshold value, configuring the user interface screen to include the recommended therapy parameter value and the graphical representation of the current therapy parameter value.

[0119] Example 17. The method of example 16, further comprising: determining, by the processing circuitry, the threshold value based on a patient sensation threshold corresponding to the therapy parameter value.

[0120] Example 18. The method of any of examples 15 through 17, wherein configuring the user interface screen of the user interface to include the graphical representation of the recommended therapy parameter value comprises: configuring, by the processing circuitry, the user interface screen to include the graphical representation of the recommended therapy parameter value in response to user interaction with the user interface screen.

[0121] Example 19. The method of any of examples 15 through 18, further comprising: determining, by the processing circuitry, the recommended therapy parameter value during an initial configuration session with a clinician programmer.

[0122] Example 20. The method of any of examples 15 through 19, wherein the recommended therapy parameter value comprises a sub sensory therapy parameter value that is below a sensory threshold of the patient.

[0123] Example 21. The system of any of examples 15 through 20, wherein the user interface is configured to: receive user input selecting the recommended therapy parameter value; and responsive to the user input selecting the recommended therapy parameter value, set the current therapy parameter value to the recommended therapy parameter.

[0124] Example 22. The method of any of examples 15 through 21, wherein the system further comprises the display device.

[0125] Example 23. The method of any of examples 14 through 22, wherein the recommended therapy parameter value comprises one or more of: a current amplitude; a pulse width; or a pulse frequency.

[0126] Example 24. The method of any of examples 15 through 23, wherein the system further comprises an implantable medical device (IMD) that includes the memory, wherein the IMD is configured to deliver the patient therapy.Docket No.: A0012533W001 / 1123-897W001

[0127] Example 25. The method of any of examples 15 through 24, further comprising: adjusting the recommended parameter value based on one or more of a sensed physiological signal or clinician input.

[0128] Example 26. The method of any of examples 15 through 25, wherein the system further comprises an implantable medical device (IMD) configured to deliver the patient therapy, and wherein the patient therapy comprises neuromodulation therapy.

[0129] Example 27. The method of example 26, wherein the neuromodulation therapy comprises sacral neuromodulation (SNM) therapy.

[0130] Example 28. The method of example 26, wherein the neuromodulation therapy comprises pudendal neuromodulation therapy.

[0131] Example 29. A non-transitory computer-readable medium storing instructions that when executed cause processing circuitry to: control a display device to present a user interface screen of a user interface to include a graphical representation of a current therapy parameter value that at least partially defines the patient therapy; determine that a recommended therapy parameter value for a patient therapy is stored in a memory of the system; and responsive to determining that the recommended therapy parameter value is stored in the memory, configure the user interface screen of the user interface to include a graphical representation of the recommended therapy parameter value with the graphical representation of the current therapy parameter value; receive, via the user interface, user input adjusting the current therapy parameter value; control the user interface screen to update the current therapy parameter value according to the user input; and control a medical device to deliver the patient therapy according to the updated current therapy parameter value.

[0132] The techniques of this disclosure may be implemented, at least in part, in hardware, software, firmware or any combination thereof. For example, various aspects of the described techniques may be implemented within one or more processors or processing circuitry, including one or more microprocessors, digital signal processors (DSPs), application specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), or any other equivalent integrated or discrete logic circuitry, as well as any combinations of such components. The term “processor” or “processing circuitry” may generally refer to any of the foregoing logic circuitry, alone or in combination with other logic circuitry, or any other equivalent circuitry. A control unit including hardware may also perform one or more of the techniques of this disclosure.

[0133] Such hardware, software, and firmware may be implemented within the same device or within separate devices to support the various operations and functions described in this disclosure. In addition, any of the described units, circuits or components may be implemented together or separately as discrete but interoperable logic devices. Depiction of different featuresDocket No.: A0012533W001 / 1123-897W001 as circuits or units is intended to highlight different functional aspects and does not necessarily imply that such circuits or units must be realized by separate hardware or software components. Rather, functionality associated with one or more circuits or units may be performed by separate hardware or software components or integrated within common or separate hardware or software components.

[0134] The techniques described in this disclosure may also be embodied or encoded in a computer-readable medium, such as a computer-readable storage medium, containing instructions that may be described as non-transitory media. Instructions embedded or encoded in a computer-readable storage medium may cause a programmable processor, or other processor, to perform the method, e.g., when the instructions are executed. Computer readable storage media may include random access memory (RAM), read only memory (ROM), programmable read only memory (PROM), erasable programmable read only memory (EPROM), electronically erasable programmable read only memory (EEPROM), flash memory, a hard disk, a CD-ROM, a floppy disk, a cassette, magnetic media, optical media, or other computer readable media.

[0135] Various examples have been described. These and other examples are within the scope of the following claims.

Claims

Docket No.: A0012533W001 / 1123-897W001 WHAT IS CLAIMED IS:

1. A system comprising:a memory configured to store a recommended therapy parameter value for a patient therapy;processing circuitry configured to:control a display device to present a user interface screen of a user interface to include a graphical representation of a current therapy parameter value that at least partially defines the patient therapy;determine that the recommended therapy parameter value is stored in the memory; andresponsive to determining that the recommended therapy parameter value is stored in the memory, configure the user interface screen of the user interface to include a graphical representation of the recommended therapy parameter value with the graphical representation of the current therapy parameter value;receive, via the user interface, user input adjusting the current therapy parameter value;control the user interface screen to update the current therapy parameter value according to the user input; andcontrol a medical device to deliver the patient therapy according to the updated current therapy parameter value.

2. The system of claim 1, wherein the processing circuitry is configured to determine that the recommended therapy parameter value is stored in the memory by at least:determining that the current therapy parameter value is less than a threshold value; and responsive to determining that the current therapy parameter value is less than the threshold value, configuring the user interface screen to include the recommended therapy parameter value and the graphical representation of the current therapy parameter value.

3. The system of claim 2, wherein the processing circuitry is configured to determine the threshold value based on a patient sensation threshold corresponding to the therapy parameter value.Docket No.: A0012533W001 / 1123-897W001 4. The system of any of claims 1 through 3, wherein the processing circuity is configured to configure the user interface screen of the user interface to include the graphical representation of the recommended therapy parameter value by at least:configuring the user interface screen to include the graphical representation of the recommended therapy parameter value in response to user interaction with the user interface screen.

5. The system of any of claims 1 through 4, wherein the processing circuitry is configured to determine the recommended therapy parameter value during an initial configuration session with a clinician programmer.

6. The system of any of claims 1 through 5, wherein the recommended therapy parameter value comprises a subsensory therapy parameter value that is below a sensory threshold of the patient.

7. The system of any of claims 1 through 6, wherein the user interface is configured to: receive user input selecting the recommended therapy parameter value; and responsive to the user input selecting the recommended therapy parameter value, set the current therapy parameter value to the recommended therapy parameter.

8. The system of any of claims 1 through 7, further comprising the display device.

9. The system of any of claims 1 through 8, wherein the recommended therapy parameter value comprises one or more of:a current amplitude;a pulse width; ora pulse frequency.

10. The system of any of claims 1 through 9, wherein the processing circuitry is further configured to adjust the recommended parameter value based on one or more of a sensed physiological signal or clinician input.

11. The system of any of claims 1 through 10, further comprising an implantable medical device (IMD) that includes the memory, wherein the IMD is configured to deliver the patient therapy.Docket No.: A0012533W001 / 1123-897W001 12. The system of any of claims 1 through 11, wherein the recommended parameter value comprises a first recommended parameter value corresponding to a first therapy program of a plurality of programs, and wherein, for a second therapy program of the plurality of therapy programs, the processing circuitry is configured to:determine that a second recommended therapy parameter value corresponding to the second therapy program is stored in the memory; andresponsive to determining that the second recommended therapy parameter value is stored in the memory, configure the user interface screen of the user interface to include a graphical representation of the second recommended therapy parameter value.

13. The system of any of claims 1 through 12, wherein the system further comprises an implantable medical device (IMD) configured to deliver the patient therapy, and wherein the patient therapy comprises neuromodulation therapy.

14. The system of any of claims 1 through 13, wherein the patient therapy comprises at least one of sacral neuromodulation (SNM) therapy, tibial neuromodulation therapy, or pudendal neuromodulation therapy.

15. A non-transitory computer-readable medium storing instructions that, when executed, cause the processing circuitry to perform the functions of any of claims 1 through 14.